Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Furlan

Showing results (151-160 of 225) with videos related to

Pageof 23
Sort By:
Molecular Neurodegeneration|December 16, 2014
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53Silvia Rossi, Caterina Motta, Valeria Studer, et al.
Frontiers in Neurology|February 15, 2019
Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple SclerosisMario Stampanoni Bassi, Antonietta Gentile, Ennio Iezzi, et al.
Clinical Science (London, England : 1979)|February 21, 2015
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosisGabriella Ruocco, Silvia Rossi, Caterina Motta, et al.
Brain, Behavior, and Immunity|October 26, 2017
Synapsin I deletion reduces neuronal damage and ameliorates clinical progression of experimental autoimmune encephalomyelitisFabrizia C Guarnieri, Serena Bellani, Latefa Yekhlef, et al.
Journal of Neuroinflammation|April 16, 2018
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosisMario Stampanoni Bassi, Ennio Iezzi, Girolama A Marfia, et al.
Plos One|July 7, 2011
T regulatory cells are markers of disease activity in multiple sclerosis patientsDacia Dalla Libera, Diletta Di Mitri, Alessandra Bergami, et al.
Brain : a Journal of Neurology|March 23, 2013
Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosisValérie Jolivel, Felix Luessi, Joumana Masri, et al.
Acta Neuropathologica|January 6, 2018
Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterationsIlaria Prada, Martina Gabrielli, Elena Turola, et al.
Anesthesiology|July 24, 2023
Indoleamine 2,3-Dioxygenase Deletion to Modulate Kynurenine Pathway and to Prevent Brain Injury after Cardiac Arrest in MiceAurora Magliocca, Carlo Perego, Francesca Motta, et al.
Frontiers in Aging Neuroscience|September 27, 2021
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple SclerosisMario Stampanoni Bassi, Luana Gilio, Ennio Iezzi, et al.
Pageof 23

Showing results (151-160 of 225) with videos related to

Sort By:
Pageof 23
Molecular Neurodegeneration|December 16, 2014
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53Silvia Rossi, Caterina Motta, Valeria Studer, et al.
Frontiers in Neurology|February 15, 2019
Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple SclerosisMario Stampanoni Bassi, Antonietta Gentile, Ennio Iezzi, et al.
Clinical Science (London, England : 1979)|February 21, 2015
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosisGabriella Ruocco, Silvia Rossi, Caterina Motta, et al.
Brain, Behavior, and Immunity|October 26, 2017
Synapsin I deletion reduces neuronal damage and ameliorates clinical progression of experimental autoimmune encephalomyelitisFabrizia C Guarnieri, Serena Bellani, Latefa Yekhlef, et al.
Journal of Neuroinflammation|April 16, 2018
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosisMario Stampanoni Bassi, Ennio Iezzi, Girolama A Marfia, et al.
Plos One|July 7, 2011
T regulatory cells are markers of disease activity in multiple sclerosis patientsDacia Dalla Libera, Diletta Di Mitri, Alessandra Bergami, et al.
Brain : a Journal of Neurology|March 23, 2013
Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosisValérie Jolivel, Felix Luessi, Joumana Masri, et al.
Acta Neuropathologica|January 6, 2018
Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterationsIlaria Prada, Martina Gabrielli, Elena Turola, et al.
Anesthesiology|July 24, 2023
Indoleamine 2,3-Dioxygenase Deletion to Modulate Kynurenine Pathway and to Prevent Brain Injury after Cardiac Arrest in MiceAurora Magliocca, Carlo Perego, Francesca Motta, et al.
Frontiers in Aging Neuroscience|September 27, 2021
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple SclerosisMario Stampanoni Bassi, Luana Gilio, Ennio Iezzi, et al.
Pageof 23